- Home
- TWLO vs QGEN Comparison
TWLO vs QGEN Comparison
Compare TWLO & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWLO
- QGEN
- Stock Information
- Founded
- TWLO 2008
- QGEN 1986
- Country
- TWLO United States
- QGEN Netherlands
- Employees
- TWLO N/A
- QGEN N/A
- Industry
- TWLO Computer Software: Prepackaged Software
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TWLO Technology
- QGEN Health Care
- Exchange
- TWLO Nasdaq
- QGEN Nasdaq
- Market Cap
- TWLO 11.4B
- QGEN 9.9B
- IPO Year
- TWLO 2016
- QGEN 1996
- Fundamental
- Price
- TWLO $111.94
- QGEN $46.01
- Analyst Decision
- TWLO Buy
- QGEN Buy
- Analyst Count
- TWLO 23
- QGEN 8
- Target Price
- TWLO $93.74
- QGEN $51.86
- AVG Volume (30 Days)
- TWLO 2.3M
- QGEN 818.9K
- Earning Date
- TWLO 02-13-2025
- QGEN 02-05-2025
- Dividend Yield
- TWLO N/A
- QGEN 2.87%
- EPS Growth
- TWLO N/A
- QGEN N/A
- EPS
- TWLO N/A
- QGEN 0.41
- Revenue
- TWLO $4,339,151,000.00
- QGEN $1,966,174,000.00
- Revenue This Year
- TWLO $8.62
- QGEN $2.78
- Revenue Next Year
- TWLO $7.82
- QGEN $5.45
- P/E Ratio
- TWLO N/A
- QGEN $110.95
- Revenue Growth
- TWLO 5.77
- QGEN 0.62
- 52 Week Low
- TWLO $52.51
- QGEN $39.03
- 52 Week High
- TWLO $117.92
- QGEN $47.44
- Technical
- Relative Strength Index (RSI)
- TWLO 56.46
- QGEN 60.66
- Support Level
- TWLO $105.53
- QGEN $45.10
- Resistance Level
- TWLO $117.92
- QGEN $46.26
- Average True Range (ATR)
- TWLO 3.42
- QGEN 0.75
- MACD
- TWLO -0.26
- QGEN 0.06
- Stochastic Oscillator
- TWLO 51.69
- QGEN 83.01
About TWLO Twilio Inc.
Twilio is a cloud-based communications platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).